Literature DB >> 4613371

Immune responsiveness in Hodgkin's disease.

P M Denton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4613371      PMCID: PMC2149066     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  15 in total

1.  Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease.

Authors:  B Johansson; G Klein; W Henle; G Henle
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

2.  Incidence of antibody to EB virus, herpes simplex, and cytomegalovirus in Hodgkin's disease.

Authors:  J M Goldman; A C Aisenberg
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

3.  Pathogenesis of Hodgkin's disease.

Authors:  S E Order; S Hellman
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

4.  Hodgkin's disease: evidence for a tumor-associated antigen.

Authors:  S E Order; M Porter; S Hellman
Journal:  N Engl J Med       Date:  1971-08-26       Impact factor: 91.245

5.  Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.

Authors:  R C Young; M P Corder; H A Haynes; V T DeVita
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

6.  Lymphocyte transformation changes during the clinical course of Hodgkin's disease.

Authors:  S M Jackson; J V Garrett; A W Craig
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

7.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

8.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

9.  [Stimulation of peripheral human lymphocytes in vitro with Zn 2+ in patients with lymphogranulomatosis and chronic lymphatic leukemia].

Authors:  H Rühl; H Scholle; H Krichner
Journal:  Acta Haematol       Date:  1971       Impact factor: 2.195

10.  Reticuloendothelial system phagocytic function in patients with Hodgkin's disease.

Authors:  J N Sheagren; J B Block; S M Wolff
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  1 in total

1.  T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.

Authors:  S V Payne; D B Jones; D G Haegert; J L Smith; D H Wright
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.